BackBiotech Acquisition Co - Units (1 Ord Class A & 1/2 War) Overview

Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) Total Assets

Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War)'s total assets is $230M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$231.39M
0.30% YoYΔ $699636.00 vs prior year quarter

Peer trimmed avg / median

Loading

Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) Total Assets History

Loading

Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) vs. peers: Total Assets Comparison

Loading

Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) (BIOTU) FAQ

As of the most recent data (September 2022), BIOTU shows a total assets of $230M. That compares with $230M in the prior-year period — up 0.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOTU's total assets is now $230M (was $230M) — a 0.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) is outperforming or lagging.

Tracking BIOTU's total assets over time shows whether Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $230M in the prior-year period — up 0.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $230M) with ownership activity and broader fundamentals.